v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ 37,855 $ (3,082)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 27,567 27,762
Non-cash operating lease costs 21,663 20,669
Stock-based compensation 34,949 39,700
Amortization of discount and debt issue costs 504 506
Other, net 1,283 753
Change in operating assets and liabilities, net of businesses acquired:    
Patient accounts receivable, net (14,402) 2,318
Prepaid expenses and other current assets 30,810 (15,179)
Accounts payable 3,946 (277)
Accrued payroll expenses 5,430 11,725
Operating lease liabilities (22,536) (23,498)
Other accrued expenses 5,952 (93)
Net cash provided by operating activities 133,021 61,304
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (22,761) (14,923)
Acquisitions of businesses, net of cash acquired (9,038) 0
Net cash used in investing activities (31,799) (14,923)
CASH FLOWS FROM FINANCING ACTIVITIES    
Payments of long-term debt (7,250) (3,625)
Taxes related to net share settlement of equity awards (24,414) (8,398)
Proceeds from the exercise of stock options 5,368 0
Repurchases of common stock (97,625) 0
Net cash used in financing activities (123,921) (12,023)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (22,699) 34,358
Cash and cash equivalents - beginning of period 248,642 154,571
CASH AND CASH EQUIVALENTS – END OF PERIOD 225,943 188,929
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest, net 8,185 8,753
Cash paid for taxes, net of refunds 1,041 1,459
SUPPLEMENTAL DISCLOSURES OF NON CASH INVESTING AND FINANCING ACTIVITIES    
Contingent consideration incurred in acquisitions of businesses 3,646 0
Acquisition of property and equipment included in liabilities $ 5,142 $ 2,286